243 related articles for article (PubMed ID: 21163250)
1. The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis.
Chen J; Xie L; Toyama S; Hünig T; Takahara S; Li XK; Zhong L
Int Immunopharmacol; 2011 May; 11(5):610-7. PubMed ID: 21163250
[TBL] [Abstract][Full Text] [Related]
2. Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody can prevent rat cardiac allograft rejection.
Kitazawa Y; Fujino M; Sakai T; Azuma H; Kimura H; Isaka Y; Takahara S; Hünig T; Abe R; Li XK
J Heart Lung Transplant; 2008 Apr; 27(4):362-71. PubMed ID: 18374871
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium bovis Bacillus Calmette-Guérin killed by extended freeze-drying reduces colitis in mice.
Lagranderie M; Kluge C; Kiefer-Biasizzo H; Abolhassani M; Nahori MA; Fitting C; Huerre M; Bandeira A; Bercovier H; Marchal G
Gastroenterology; 2011 Aug; 141(2):642-52, 652.e1-4. PubMed ID: 21683076
[TBL] [Abstract][Full Text] [Related]
5. Orally administered lactoperoxidase ameliorates dextran sulfate sodium-induced colitis in mice by up-regulating colonic interleukin-10 and maintaining peripheral regulatory T cells.
Shin K; Horigome A; Yamauchi K; Yaeshima T; Iwatsuki K
Int Immunopharmacol; 2009 Nov; 9(12):1387-93. PubMed ID: 19723594
[TBL] [Abstract][Full Text] [Related]
6. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
[TBL] [Abstract][Full Text] [Related]
7. Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum.
Yao J; Wang JY; Lai MG; Li YX; Zhu HM; Shi RY; Mo J; Xun AY; Jia CH; Feng JL; Wang LS; Zeng WS; Liu L
Mol Pharm; 2011 Apr; 8(2):488-97. PubMed ID: 21271712
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
[TBL] [Abstract][Full Text] [Related]
10. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
Sharabi A; Lapter S; Mozes E
J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
[TBL] [Abstract][Full Text] [Related]
11. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
12. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.
Fantini MC; Rizzo A; Fina D; Caruso R; Sarra M; Stolfi C; Becker C; Macdonald TT; Pallone F; Neurath MF; Monteleone G
Gastroenterology; 2009 Apr; 136(4):1308-16, e1-3. PubMed ID: 19192480
[TBL] [Abstract][Full Text] [Related]
13. Prevention of graft-versus-host diseases by in vivo supCD28mAb-expanded antigen-specific nTreg cells.
Kitazawa Y; Li XK; Liu Z; Kimura H; Isaka Y; Hünig T; Takahara S
Cell Transplant; 2010; 19(6):765-74. PubMed ID: 20573297
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.
Aharoni R; Sonego H; Brenner O; Eilam R; Arnon R
Immunol Lett; 2007 Oct; 112(2):110-9. PubMed ID: 17719654
[TBL] [Abstract][Full Text] [Related]
15. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
[TBL] [Abstract][Full Text] [Related]
16. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.
Bleich A; Janus LM; Smoczek A; Westendorf AM; Strauch U; Mähler M; Hedrich HJ; Fichtner-Feigl S; Schölmerich J; Falk W; Hofmann C; Obermeier F
Gastroenterology; 2009 Jan; 136(1):278-87. PubMed ID: 18952084
[TBL] [Abstract][Full Text] [Related]
17. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
[TBL] [Abstract][Full Text] [Related]
18. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease.
Wang Y; Liu XP; Zhao ZB; Chen JH; Yu CG
J Dig Dis; 2011 Aug; 12(4):286-94. PubMed ID: 21791023
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
